ENTECAVIR TEVA^®
(entecavir)
TEVA
HK Reg. No. HK-68822 (27 Aug, 2025)

Composition:²

• Available in the dosage form of 0.5 mg film-coated tablets

Indication:²

• Indicated for chronic hepatitis B virus (HBV) infection in adults. This medicine can be used in people with
either compensated or decompensated liver disease
• Indicated for chronic HBV infection in children and adolescents aged 2 to less than 18 years. This medicine can
be used in children with compensated liver disease

References

2. Health Products Regulatory Authority, Ireland. Package leaflet: Information for the user: Entecavir Teva 0.5 mg Film-coated Tablets. Revised May 2017.